Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older

NCT01165229 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

14819

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster
Herpes Zoster Vaccine

Interventions

BIOLOGICAL: Herpes Zoster Vaccine GSK1437173A
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline